Orphan drug designation is a special status granted by regulatory authorities to drugs intended for the treatment of rare diseases or conditions affecting fewer than 200,000 people in the United States. This designation provides various incentives, such as tax credits, grants, and seven years of market exclusivity after approval, encouraging pharmaceutical companies to develop treatments for conditions that might otherwise lack research funding and interest due to their limited patient population.
congrats on reading the definition of orphan drug designation. now let's actually learn it.